ALDOA Expression in Bladder Urothelial Carcinoma

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAssiut University

About this trial

1. Study the immunohistochemical expression of ALDOA in bladder urothelial cancer. 2. Correlate between ALDOA expression in specimens and different cilnicopathological factors. 3. Correlate between ALDOA expression and urothelial cancer prognosis and survival.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All cases diagnosed as bladder urothelial cancer with known follow-up data and presence of muscle proper detected in the specimens.

Disqualifiers

Subtypes of bladder cancer other than urothelial carcinoma subtype.

Cases of urothelial carcinoma without known follow up data.

Cases of urothelial carcinoma without muscle proper detected in the specimen.

Trial population

The study will be conducted using formalin fixed paraffin embedded blocks of fifty cases of urothelial carcinomas . These blocks will be obtained from laboratory archives of the Pathology Department, Assiut University Hospital, Faculty of Medicine. Clinical data for this study will be obtained from laboratory archives of the pathology department, Assiut University Hospital, Assiut University.

Trial design

Design model

Case-control

Time perspective

Retrospective

Treatments tested in this trial

  • Immunohistochemistry

    Genetic

    Immunohistochemical expression of ALDOA in bladder urothelial carcinoma

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Evaluate the immunohistochemical expression of ALDOA in bladder urothelial carcinoma.

Microscopic examination of bladder urothelial carcinoma spicemens and staining them with ALDOA marker

Time frame
Baseline

Secondary outcomes

1

Evaluate relation between ALDOA expression and cilnicopathological features and patient survival.

Correlate between ALDOA expression and the different clinicopathological factors of patients and their survival.

Time frame
Baseline

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: